PRAVACHOL

This brand name is authorized in Australia, Turkey, United States

Active ingredients

The drug PRAVACHOL contains one active pharmaceutical ingredient (API):

1 Pravastatin UNII 3M8608UQ61 - PRAVASTATIN SODIUM

Pravastatin is a competitive inhibitor of 3-hydroxy–3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the enzyme catalyzing the early rate limiting step in cholesterol biosynthesis, and produces its lipid lowering effect in two ways. Read about Pravastatin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PRAVACHOL Tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C10AA03	Pravastatin	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors
Discover more medicines within C10AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2833D, 2834E, 8197K, 8829Q, 9237E, 9238F, 9239G, 9240H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699525016775, 8699525016782, 8699525016799
Country: US	FDA, National Drug Code	Identifier(s): 0003-5178, 0003-5194